The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Table 2
Dietary intake of participants at the baseline and after 8 weeks of intervention.
Variables
ALA group
Placebo group
Energy (kcal/day)
Before
2227.57 (363.28)
2269.74 (356.95)
0.62
0.62
After
2176.22 (282.93)
2240.28 (345.06)
Carbohydrate (g/day)
Before
302.61 (52.31)
307.73 (49.54)
0.67
0.89
After
303.17 (50.76)
309.06 (47.16)
Carbohydrate (%)
Before
54.28 (2.46)
54.24 (2.40)
0.94
0.86
After
55.60 (4.63)
55.37 (4.80)
Protein (g/day)
Before
61.20 (9.28)
60.31 (10.48)
0.70
0.33
After
60.02 (7.49)
60.66 (9.87)
Protein (%)
Before
11.03 (0.74)
10.64 (0.94)
0.06
0.43
After
11.04 (0.41)
10.82 (0.54)
Fat (g/day)
Before
85.80 (14.91)
88.61 (15.99)
0.45
0.72
After
80.38 (14.08)
84.59 (19.81)
Fat (%)
Before
34.67 (2.37)
35.10 (2.36)
0.45
0.98
After
33.34 (4.61)
33.79 (4.90)
Vitamin A (μg/day)
Before
646.30 (132.88)
618.13 (92.49)
0.30
0.66
After
647.51 (126.12)
622.71 (100.52)
Vitamin E (mg/day)
Before
18.63 (4.12)
19.23 (4.20)
0.54
0.34
After
18.20 (3.82)
18.15 (4.51)
Vitamin C (mg/day)
Before
79.20 (10.50)
83.05 (13.06)
0.17
0.43
After
81.36 (10.66)
86.42 (15.18)
Riboflavin (mg/day)
Before
1.60 (0.43)
1.63 (0.49)
0.74
0.86
After
1.59 (0.40)
1.62 (0.52)
Zinc (mg/day)
Before
9.68 (1.93)
9.95 (2.20)
0.59
0.84
After
9.94 (1.94)
10.28 (2.23)
Selenium (μg/day)
Before
67.06 (11.59)
64.09 (15.16)
0.36
0.75
After
67.83 (11.91)
65.17 (15.80)
Iron (mg/day)
Before
8.89 (2.66)
9.67 (3.50)
0.29
0.75
After
9.14 (2.25)
10.06 (2.65)
The results are described as mean (SD). according to independent -test at baseline; time to group interaction according to two-way repeated measure ANOVA.
